Lupus Vulgaris Following Bcg Vaccination

Area of Science:

• Dermatology
• Infectious Diseases
• Vaccinology

Background:

• Bacille Calmette-Guérin (BCG) vaccination is widely used to prevent tuberculosis.
• Cutaneous tuberculosis can manifest in various forms, including lupus vulgaris.
• Rarely, BCG vaccination sites can be associated with atypical mycobacterial infections or inflammatory reactions.

Observation:

• Three pediatric cases of lupus vulgaris developing at the site of BCG vaccination were identified.
• Lesions presented in all patients before the age of 15 years.
• Clinical and histological examination revealed lesions indistinguishable from spontaneous lupus vulgaris.

Findings:

• The reported cases demonstrate a potential link between BCG vaccination and the subsequent development of lupus vulgaris.
• Histopathological analysis confirmed the diagnosis, showing no distinguishing features from non-vaccine-associated lupus vulgaris.
• Successful treatment was achieved using a combination of streptomycin and isonicotinic acid hydrazide over a 1-year period.

Implications:

• This suggests that BCG vaccination sites may serve as a locus for the development of lupus vulgaris in susceptible individuals.
• Early diagnosis and appropriate anti-mycobacterial therapy are crucial for managing these vaccine-site associated lesions.
• Further research may be warranted to elucidate the precise mechanisms underlying this association and to refine management strategies.